Restless legs syndrome

Current Treatment Options in Neurology

Volumn 6, Issue 3, 2004, Pages 209-219

  Lesage, Suzanne ^a   Earley, Christopher J ^b  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; ASCORBIC ACID; BENSERAZIDE; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CARBAMAZEPINE; CARBIDOPA; CIMETIDINE; CLONAZEPAM; DILTIAZEM; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FERRITIN; GABAPENTIN; IRON; LEVODOPA; METOCLOPRAMIDE; NEUROLEPTIC AGENT; OPIATE; PERGOLIDE; PRAMIPEXOLE; QUINIDINE; RANITIDINE; ROPINIROLE; SELEGILINE; TETRACYCLINE; TRIAMTERENE; UNINDEXED DRUG; VERAPAMIL;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ATAXIA; BODY WEIGHT DISORDER; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL TRIAL; CONFUSION; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIPLOPIA; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG EXCRETION; DRUG HALF LIFE; DYSARTHRIA; DYSPHORIA; DYSPNEA; EUPHORIA; EXCITABILITY; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; IRON DEFICIENCY ANEMIA; IRRITABILITY; LOW DRUG DOSE; MALAISE; MENTAL DISEASE; MUSCLE CRAMP; NAUSEA; NERVOUSNESS; ORTHOSTATIC HYPERTENSION; PATIENT CARE; PERIPHERAL EDEMA; POLYSOMNOGRAPHY; PROTEIN BINDING; PRURITUS; QUALITY OF LIFE; RESPIRATION DEPRESSION; RESTLESS LEGS SYNDROME; REVIEW; RHINITIS; SLEEP DISORDER; SOMNOLENCE; TREMOR; URINE RETENTION; VISUAL DISORDER; VOMITING; XEROSTOMIA;

EID: 3142715227     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-004-0013-8     Document Type: Review

References (47)

1. Ekbom KA: Restless legs syndrome. Neurology 1960, 10:868-873.
2. Allen R, Hening W, Montplaisir J, et al.: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003, 4:101-119.
3. Saletu M, Anderer P, Saletu B, et al.:EEG mapping in patients with restless legs syndrome as compared with normal controls. Psychiatry Res 2002, 115:49-61.
4. Earley CJ: Clinical practice: restless legs syndrome. N Engl J Med 2003, 348:2103-2109.
5. Thorpe M: Periodic limb movement disorder and restless leg syndrome. In The International Classification of Sleep Disorders Diagnostic and Coding Manual. Edited by Thorpe M. Lawrence: Allen Press; 1990:65-71.
6. Bonati MT, Ferini-Strambi L, Aridon P, et al.: Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003, 126:1485-1492.
7. Desautels A, Turecki G, Montplaisir J, et al.:Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001, 69:1266-1270.
8. Tan EK, Seah A, See SJ, et al.: Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001, 16:577-579.
9. Lavigne GJ, Montplaisir JY: Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994, 17:739-743.
10. Winkelman JW, Chertow GM, Lazarus JM: Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996, 28:372-378.
11. Hui D, Wong T, Li T, et al.: Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis. Med Sci Monit 2002, 8:331-336.
12. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C: Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002, 17:1072-1076.
13. Manconi M, Govoni V, Cesnik E, et al.: Epidemiology of restless legs syndrome in a population of 606 pregnant women. Sleep 2003, 26:A330-331.
14. Lee KA, Zaffke ME, Baratte-Beebe K: Restless legs syndrome and sleep distrubance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med 2001, 10:335-341.
15. O'Keeffe ST, Gavin K, Lavan JN: Iron status and restless legs syndrome in the elderly. Age Ageing 1994, 23:200-203.
16. Sun ER, Chen CA, Ho G, et al.: Iron and the restless legs syndrome. Sleep 1998, 21:371-377.
17. Comella CL: Restless legs syndrome: treatment with dopaminergic agents. Neurology 2002, 58:S87-S92.
18. Silber MH, Shepard JW, Jr., Wisbey JA: Pergolide in the management of restless legs syndrome: an extended study. Sleep 1997, 20:878-882.
19. Silber M, Girish M, Izurieta R: Pramipexole in the management of restless legs syndrome: an extended study. Sleep 2003, 26:819-821.
20. Allen RP, Earley CJ: Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996, 19:205-213.
21. Hening W, Allen R, Earley C, et al.: The treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine review. Sleep 1999, 22:970-999.
22. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al.: Treatment of restless legs syndrome with gabapentin: a double-blind, crossover study. Neurology 2002, 59:1573-1579.
23. Chervin RD, Archbold KH, Dillon JE, et al.: Associations between symptoms of inattention, hyperactivity, restless leg, and periodic leg movements. Sleep 2002, 25:213-218.
24. Kryger MH, Otake K, Foerster J: Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers. Sleep Med 2002, 3:127-132.
25. Walters AS, Mandelbaum DE, Lewin DS, et al.: Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. Pediatr Neurol 2000, 22:182-186.
26. Phillips B, Young T, Finn L, et al.:Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000, 160:2137-2141.
27. Ohayon MM, Roth T: Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002, 53:547-554.
28. Early CJ, Yaffee JB, Allen RP: Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 1998, 51:1599-1602.
29. Telstad W, Sorensen O, Larsen S, et al.: Treatment of the restless legs syndrome with carbamazepine: a double blind study. BMJ 1984, 288:444-446.
30. von Scheele C, Kempi V: Long-term effect of dopaminergic drugs in restless legs: a 2-year follow-up. Arch Neurol 1990, 47:1223-1224.
31. Benes H, Kurella B, Kummer J, et al.: Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial. Sleep 1999, 22:1073-1081.
32. Kaplan PW, Allen RP, Buchholz DW, Walters JK: A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 1993, 16:717-723.
33. Trenkwalder C, Collado Seidel V, Kazenwadel J, et al.: One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome? Mov Disord 2003, 18:1184-1189.
34. Wetter TC, Trenkwalder C, Stiasny K, et al.: [Treatment of idiopathic and uremic restless legs syndrome with L-dopa - a double-blind cross-over study]. Wien Med Wochenschr 1995, 145:525-527.
35. Saletu M, Anderer P, Hogl B, et al.: Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome. J Neural Transm 2003, 110:611-626.
36. Wetter TC, Stiasny K, Winkelmann J, et al.: A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999, 52:944-950.
37. Pieta J, Millar T, Zacharias J, et al.: Effect of pergolide on restless legs and leg movements in sleep in uremic patients. Sleep 1998, 21:617-622.
38. Stiasny K, Wetter TC, Winkelmann J, et al.: Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 2001, 56:1399-1402.
39. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B: Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999, 52:938-943.
40. Happe S, Sauter C, Klosch G, et al.: Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 2003, 48:82-86.
41. Ondo W: Ropinirole for restless legs syndrome. Mov Disord 1999, 14:138-140.
42. Thorp ML, Morris CD, Bagby SP: A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis 2001, 38:104-108.
43. Schenk CH, Mahowald MW: Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 1996, 100:333-337.
44. Bezerra ML, Martinez JV: Zolpidem in restless legs syndrome. Eur Neurol 2002, 48:180-181.
45. Walters AS, Wagner ML, Hening WA, et al.: Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993, 16:327-332.
46. Walters AS, Winkelmann J, Trenkwalder C, et al.: Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001, 16:1105-1109.
47. Early CJ, Heckler D, Allen RP: IV iron treatment for the restless legs syndrome (RLS). Sleep 2001, 24:A359.